Biosimilar Trends Highlight Top News of the Week in Specialty Pharmacy

5. Amgen and Avalere Partner on Outcomes-Based Contracting for Rheumatoid Arthritis Treatment

Strategic partnership will advance the use of data in value-based care.

https://www.specialtypharmacytimes.com/news/amgen-and-avalere-partner-on-outcomes-based-contracting-for-rheumatoid-arthritis-treatment

4. Global Effort Needed to Cure HIV

The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.

https://www.specialtypharmacytimes.com/news/global-effort-needed-to-cure-hiv 3. The Hunger for an Integrated, All-Inclusive Specialty Pharmacy Management System

Current platforms are not designed for the dynamic needs of today’s specialty pharmacy providers.

https://www.specialtypharmacytimes.com/news/the-hunger-for-an-integrated-all-inclusive-specialty-pharmacy-management-system

2. Annual Medical Pharmacy Trend Report Illustrates Impact of Costly Specialty Drugs

Report from Magellan Rx Management shows high-cost specialty drugs require effective management of the medical benefit.

https://www.specialtypharmacytimes.com/news/annual-medical-pharmacy-trend-report-illustrates-impact-of-costly-specialty-drugs

1. The Road Ahead for Biosimilars in 2017 Holds Multiple Challenges to Overcome

Amgen’s 2017 Trends in Biosimilars report examines commercialization and distribution issues in the biosimilar space.

https://www.specialtypharmacytimes.com/news/the-road-ahead-for-biosimilars-in-2017-holds-multiple-challenges-to-overcome